Australia's EchoIQ heads for worst week in seven years after US FDA setback
11/09/2026 06:23
BUZZ-Australia's EchoIQ heads for worst week in seven years after US FDA setback ** Shares of EchoIQ EIQ.AX are on track for a nearly 62% weekly loss, their worst weekly performance in seven years
** In current session, stock falls as much as 15.8% to A$0.4800, extending losses for a third consecutive session
** On Tuesday, stock plunged as much as 63.3% after the AI-powered medical software company said the U.S. FDA did not clear its application to commercialise its tool designed to detect heart failure
** YTD stock up about 91%
(Reporting by Paridhi Minda in Bengaluru)
Recent news on GrainCorp
See all newsAustralia's EchoIQ heads for worst week in seven years after US FDA setback
Morningstar says Australia's GrainCorp undervalued, sees recovery in margins
Brief: GrainCorp Targets A$20-A$30 Million Uplift In Through-The-Cycle EBITDA By End Of FY28
Australia's GrainCorp falls as company flags restructuring-driven costs
Brief: S&P Dow Jones Indices Announces Removal Of GQG Partners Inc, Graincorp From S&P/ASX 200 Index